We are live on ! Find out more
JSMC

Jess S. Morgan & Co Portfolio holdings

AUM $115M
1-Year Est. Return 16.65%
This Fund
S&P 500
This Quarter Est. Return
+12.89%
1 Year Est. Return
-16.65%
3 Year Est. Return
+69.29%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$9.45M
Cap. Flow
-$4.94M
Cap. Flow %
-3.24%
Top 10 Hldgs %
32.37%
Holding
44
New
–
Increased
28
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
CKPT
Checkpoint Therapeutics
CKPT
+$1.47M
2
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$971K
3
AXSM icon
Axsome Therapeutics
AXSM
+$911K
4
AGEN
Agenus
AGEN
+$660K
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$577K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.35M
2
PARA
Paramount Global Class B
PARA
+$2.56M
3
MNOV icon
MediciNova
MNOV
+$2.52M
4
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$2.28M
5
ORMP icon
Oramed Pharmaceuticals
ORMP
+$660K

Sector Composition

Rank Sector Weight
1 Healthcare 24.89%
2 Technology 11.42%
3 Financials 8.35%
4 Consumer Discretionary 5.21%
5 Consumer Staples 2.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
26
Amgen
AMGN
$211B
$4.02M 2.64%
16,509
+1,629
+11% +$401K
DIS icon
27
Walt Disney
DIS
$172B
$3.99M 2.62%
22,705
+2,120
+10% +$381K
CRM icon
28
Salesforce
CRM
$149B
$3.98M 2.62%
16,307
+1,245
+8% +$287K
VXUS icon
29
Vanguard Total International Stock ETF
VXUS
$153B
$3.87M 2.54%
58,840
+14,830
+34% +$971K
JNJ icon
30
Johnson & Johnson
JNJ
$645B
$3.84M 2.52%
23,288
+1,395
+6% +$231K
CAKE icon
31
Cheesecake Factory
CAKE
$4.38B
$3.76M 2.47%
69,395
-109
-0.2% -$6.3K
IFN
32
Aberdeen India Fund
IFN
$497M
$3.7M 2.43%
168,494
+2,225
+1% +$47.5K
CKPT
33
DELISTED
Checkpoint Therapeutics
CKPT
$3.32M 2.18%
112,578
+53,008
+89% +$1.47M
XLK icon
34
State Street Technology Select Sector SPDR ETF
XLK
$112B
$2.44M 1.61%
33,102
+1,312
+4% +$91.9K
QQQX icon
35
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.43B
$1.34M 0.88%
45,667
+1,200
+3% +$34K
VTI icon
36
Vanguard Total Stock Market ETF
VTI
$656B
$1.34M 0.88%
6,020
-265
-4% -$57.5K
IGV icon
37
iShares Expanded Tech-Software Sector ETF
IGV
$12.4B
$1.23M 0.81%
15,770
+120
+0.8% +$8.7K
XLV icon
38
State Street Health Care Select Sector SPDR ETF
XLV
$43.1B
$1.2M 0.79%
9,552
+28
+0.3% +$3.43K
XLP icon
39
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$915K 0.6%
13,080
+655
+5% +$45.9K
RNTX
40
Rein Therapeutics
RNTX
$68.4M
$94K 0.06%
3,750
+500
+15% +$12.5K
BMY icon
41
Bristol-Myers Squibb
BMY
$130B
– –
-53,024
Closed -$3.35M
MNOV icon
42
MediciNova
MNOV
$65.5M
– –
-498,688
Closed -$2.52M
PARA
43
DELISTED
Paramount Global Class B
PARA
– –
-56,645
Closed -$2.56M
PRVB
44
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-217,050
Closed -$2.28M
1
2

Similar funds

RCM
Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return
DIV
DCM International VI Menlo Park, California $114M AUM 73.96% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
FFC
Fure Financial Corporation Bloomington, Minnesota $122M AUM 1.51% 1-Year Est. Return
SA
SWM Advisors St. Petersburg, Florida $106M AUM 17.51% 1-Year Est. Return
MCA
Morris Capital Advisors Malvern, Pennsylvania $106M AUM 2.55% 1-Year Est. Return
SCM
Salem Capital Management Woburn, Massachusetts $126M AUM 8.82% 1-Year Est. Return
LAM
LFS Asset Management San Ramon, California $99.1M AUM

Jess S. Morgan & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Jess S. Morgan & Co held 44 positions worth $152M, up 6.6% from $143M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jess S. Morgan & Co withdrew a net $4.94M in Q2 2021, closing 4 positions and reducing 12 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $3.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Jess S. Morgan & Co added an estimated $1.47M to Checkpoint Therapeutics.

  • Jess S. Morgan & Co added most to Checkpoint Therapeutics in Q2 2021, an estimated $1.47M increase.
  • Jess S. Morgan & Co's biggest Q2 2021 reduction was Oramed Pharmaceuticals, cutting an estimated $660K.
  • Jess S. Morgan & Co fully exited Bristol-Myers Squibb in Q2 2021, selling an estimated $3.35M.
  • Jess S. Morgan & Co's ten largest holdings make up 32% of its $152M portfolio in Q2 2021.
  • Jess S. Morgan & Co opened 0 new positions and closed 4 in Q2 2021.
  • Jess S. Morgan & Co's portfolio value rose 6.6% quarter-over-quarter to $152M.

Based on Jess S. Morgan & Co's 13F filing for Q2 2021, filed 30 Nov 2021.